Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team

What are you looking for?

  • Conference Roundup
  • Contact Lenses
  • Diagnostics
  • Glaucoma
  • Myopia
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Retina
  • Spotlight Series
The evolving role of the optometrist in nonsurgical cataract management
Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team
Home > Surge in online interest for alternative dry eye therapies following eye drop recalls
  • Ocular Surface Disease

Surge in online interest for alternative dry eye therapies following eye drop recalls

Kelsey Moroz

A new study reports that the recall of contaminated eye drops in January 2023 significantly increased public interest in the safety of these products and alternative treatments for dry eye disease.

A study analyzed Internet search trends related to DED therapies using Google Trends data from April 24, 2022, to October 29, 2023.

The analysis focused on the following search terms: “dry eye vitamin,” “are eye drops safe,” “stop eye drops,” “lipiflow,” “ilux treatment,” “dry eye mask,” “dry eye warm compress,” “omega-3 for dry eyes,” “dry eye plugs,” “dry eye humidifier,” “itear,” and “IPL dry eye”. During the 40 weeks following the recalls, search interest for 7 out of 10 alternative DED therapies increased significantly. Similarly, keywords related to eye drop safety concerns also saw marked increases.

These results highlight a growing public awareness and concern regarding the safety of eye drops post-recall.

Reference
Martinyan J, Starr CE. Surge in Eye Drop Safety Concerns and Interest in Alternative Dry Eye Disease Therapy Following Eye Drop Recalls: A Cross-Sectional Google Trends Analysis. Eye Contact Lens. 2024;doi: 10.1097/ICL.0000000000001134. Epub ahead of print. PMID: 39378274.

Share

Related Content

  • Ocular Surface Disease

Childhood-onset allergic eye disease linked to greater ocular morbidity

  • Ocular Surface Disease

Perceived stress may precede worsening dry eye symptoms in young adults

  • Ocular Surface Disease

Post-menopausal women show more severe evaporative dry eye disease

  • Ocular Surface Disease

Dry eye diagnostic practices remain inconsistent worldwide, survey finds

  • Ocular Surface Disease

Spotlight on VEVYE®

  • Ocular Surface Disease

Intervening early in dry eye disease: reducing patient cost and disease burden

Share

Advisory Board

Kaleb Abbott, OD, MS, FAAO

Clark Chang, OD

Jessica Haynes, OD, FAAO, FORS, Dipl ABO

Monica Kalia, OD

Cecelia Koetting, OD, FAAO, DipABO

Roya Attar, OD, MBA, DHA, FAAO

Hardeep Kataria, OD, FAAO

Marc R. Bloomenstein, OD, FAAO

Elise Kramer, OD

See All
Optometry 360

Optometry 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

© 2026 Optometry 360 is a trademark of International Healthcare Media, LLC. All rights Reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophthalmology360 Icon